Borrelia Species in Cutaneous Lyme Borreliosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00576082 |
Recruitment Status :
Recruiting
First Posted : December 18, 2007
Last Update Posted : April 17, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Lyme Borreliosis | Other: Cutaneous biopsy |
Study Type : | Observational |
Estimated Enrollment : | 900 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | DIVERSITY OF BORRELIA SPECIES INVOLVED IN CUTANEOUS MANIFESTATIONS OF LYME BORRELIOSIS IN FRANCE |
Actual Study Start Date : | March 2008 |
Estimated Primary Completion Date : | April 2022 |
Estimated Study Completion Date : | April 2022 |

- Other: Cutaneous biopsy
Cutaneous biopsy in order to search Borrelia by means of culture and PCR in this tissue sample

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion criteria:
- Informed adult patient who signed written consent with one the following conditions:
- erythema migrans
- borrelial lymphocytoma
- acrodermatitis chronica atrophicans
Exclusion criteria:
- pregnancy or lactation
- allergy to local anesthesia
- patient who refuses biopsy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00576082
Contact: Dan LIPSKER, MD | 33.3.88.11.61.79 | dan.lipsker@chru-strasbourg.fr |
France | |
Service de Dermatologie, Hôpital Civil | Recruiting |
Strasbourg, France, 67091 | |
Contact: Dan LIPSKER, MD 33.3.88.11.61.79 dan.lipsker@chru-strasbourg.fr | |
Contact: Benoît JAULHAC, MD 33.3.90.24.37.80 benoit.jaulhac@medecine.u-strasbg.fr | |
Principal Investigator: Dan LIPSKER, MD | |
Sub-Investigator: Benoît JAULHAC, MD | |
Sub-Investigator: Bernard CRIBIER, MD | |
Sub-Investigator: Carine KIEFFER, MD | |
Sub-Investigator: Eric FROUIN, MD | |
Sub-Investigator: Pauline LEMORDANT, MD | |
Sub-Investigator: Cécile PERRIGOUARD, MD | |
Sub-Investigator: Jean-Nicolas SCRIVENER, MD | |
Sub-Investigator: Virginie LUTZ, MD | |
Service des Maladies infectieuses et tropicales, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg | Recruiting |
Strasbourg, France, 67091 | |
Contact: Yves HANSMANN, MD 33.3.69.55.09.78 yves.hansmann@chru-strasbourg.fr | |
Sub-Investigator: Yves HANSMANN, MD | |
Sub-Investigator: Guillaume CAMUSET, MD |
Principal Investigator: | Dan LISPKER, MD | Hôpitaux Universitaires de Strasbourg |
Responsible Party: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00576082 |
Other Study ID Numbers: |
3977 |
First Posted: | December 18, 2007 Key Record Dates |
Last Update Posted: | April 17, 2019 |
Last Verified: | April 2019 |
Lyme borreliosis Erythema migrans Borrelial lymphocytoma Acrodermatitis chronica atrophicans |
Borrelia burgdorferi Borrelia afzelii Borrelia garinii |
Borrelia Infections Lyme Disease Gram-Negative Bacterial Infections |
Bacterial Infections Spirochaetales Infections Tick-Borne Diseases |